Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-260678
Filing Date
2026-06-08
Accepted
2026-06-08 07:15:53
Documents
80
Period of Report
2026-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sptx-20260331.htm   iXBRL 10-Q 2797581
2 EX-31.1 sptx-ex31_1.htm EX-31.1 22309
3 EX-31.2 sptx-ex31_2.htm EX-31.2 21975
4 EX-32.1 sptx-ex32_1.htm EX-32.1 11295
5 EX-32.2 sptx-ex32_2.htm EX-32.2 11305
  Complete submission text file 0001193125-26-260678.txt   9734007

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sptx-20260331.xsd EX-101.SCH 1192632
84 EXTRACTED XBRL INSTANCE DOCUMENT sptx-20260331_htm.xml XML 1551627
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Filer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-43254 | Film No.: 261071017
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)